Integra LifeSciences Corporation (IART)
Company Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery.
It operates in two segments, Codman Specialty Surgical and Tissue Technologies.
The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services.
It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices.
In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair.
Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products.
The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally.
Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Country | United States |
IPO Date | Aug 16, 1995 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 4,396 |
CEO | Mojdeh Poul |
Contact Details
Address: 1100 Campus Road Princeton, New Jersey United States | |
Website | https://www.integralife.com |
Stock Details
Ticker Symbol | IART |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0000917520 |
CUSIP Number | 457985208 |
ISIN Number | US4579852082 |
Employer ID | 51-0317849 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Mojdeh Poul | President, Chief Executive Officer & Director |
Eric Ian Schwartz J.D. | Executive Vice President, Chief Legal Officer & Secretary |
Lea Daniels Knight | Executive Vice President & Chief Financial Officer |
Christopher Ward | Senior Director of Investor Relations |
Dr. Stuart M. Essig Ph.D. | Non- Executive Chairman |
Jeffrey A. Mosebrook | Senior Vice President of Finance & Principal Accounting Officer |
Laurene Isip | Vice President of Global Corporate Communications & Public Relations |
Michael J. McBreen | Executive Vice President & President of Codman Specialty Surgical |
Robert T. Davis Jr. | Executive Vice President & President of Tissue Technologies |
Stephen Leonard | Corporate Vice President of Global Operations & Supply Chain |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 13, 2025 | 4 | Filing |
Mar 13, 2025 | 4 | Filing |
Mar 13, 2025 | 4 | Filing |
Mar 13, 2025 | 4 | Filing |
Mar 13, 2025 | 4 | Filing |
Mar 13, 2025 | 4 | Filing |
Mar 13, 2025 | 4 | Filing |
Mar 11, 2025 | 4 | Filing |
Mar 11, 2025 | 4 | Filing |
Mar 11, 2025 | 4 | Filing |